Septerna · 2 days ago
Research Associate/Senior Research Associate, Disease Biology
Wonder how qualified you are to the job?
BiotechnologyInformation Technology
Insider Connection @Septerna
Responsibilities
Design and execute in vivo pharmacology studies to understand therapeutic mechanism in relevant disease models
Generate, analyze, document, and help interpret data to establish functional PK/PD relationships
Work collaboratively to determine the mechanism of action of drug candidates in in vivo, in vitro and ex vivo models
Be a member of multiple project teams and present results in lab, team and department meetings
Perform in literature searches, read and interpret papers to help design and trouble-shoot in vivo and in vitro experiments
Help in authoring in vivo pharmacology study designs, protocols, and reports to support regulatory filings
Follow all company policies/practices, and maintain accurate records and notebooks
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
BSc or MSc in Pharmacology, Toxicology, or related biological science
At least 4 (or 2 years with MSc) direct hands-on experience with in vivo studies or disease models in academia or the biotechnology and pharmaceutical industries
Ability to be hands on and work directly with rodent models
Experience working with other scientists to analyze, interpret, and present data
Ability to collaborate in writing protocols and trouble-shooting biological experiments
Detail-oriented and organized, with strong interpersonal skills for clear and effective communication – ability to proactively engage and collaboration with colleagues
Preferred
Experience working with primary cells or ex vivo models or in vivo species
Experience working with generation of surgical models in rodents
Previous work on therapeutic discovery and development programs in the field of endocrine, inflammatory, and metabolic diseases
Benefits
Stock options
Annual target bonus
Company
Septerna
Septerna is a biotech firm unlocking diverse drug discovery potential in G protein-coupled receptors across various diseases.
Funding
Current Stage
Growth StageTotal Funding
$250MKey Investors
RA Capital ManagementThird Rock Ventures
2023-09-12Acquired· by Vertex Pharmaceuticals
2023-07-11Series B· $150M
2022-01-27Series A· $100M
Recent News
2024-05-28
BioWorld MedTech
2024-04-10
Company data provided by crunchbase